Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Lymphoma 49Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 37Lymphoma, Follicular 37Myelodysplastic Syndromes 34Lymphoma, Non-Hodgkin 34Multiple Myeloma 32Leukemia, Myeloid, Acute 31Leukemia, Myeloid, Chronic-Phase 30Leukemia, Myeloid, Accelerated Phase 28Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Lymphocytic, Chronic, B-Cell 27Hodgkin Disease 22Blast Crisis 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Graft vs Host Disease 21Neoplasms, Plasma Cell 20Myeloproliferative Disorders 20Dendritic Cell Sarcoma, Interdigitating 20Recurrence 19Leukemia, Myelomonocytic, Chronic 17Leukemia, Biphenotypic, Acute 17Congenital Abnormalities 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Anemia, Refractory, with Excess of Blasts 15Primary Myelofibrosis 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13

Interventions

Low-Level Light Therapy 2Xylitol 1Vitamin E 1Taurine 1Standard of Care 1Saline Solution 1Radiotherapy 1Propranolol 1Mouthwashes 1Morphine 1Methylprednisolone 1Lysine Acetyltransferase 5 1Electrochemotherapy 1Cryotherapy 1Control Groups 1Bleomycin 1Betaine 1Analgesia 1Acetylcysteine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ulcer × Methylprednisolone × Clear all
NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Prometheus Laboratories

Phase 2 Completed
190 enrolled
Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡